{"product_id":"addictive-disorders-in-medical-populations-isbn-9780470740330","title":"Addictive Disorders in Medical Populations","description":"This book has a much wider focus than traditional books written about drug and alcohol addictions. This unique book is written by medical specialists who diagnose, treat and research addictive disorders in their specialities. Thus, it meets the needs of the typical medical practitioner who wants to learn about and treat patients with addictive disorders in their practices. Because alcohol and drug problems are so prevalent and affect medical conditions profoundly, the medical specialist will improve their knowledge and skill to diagnose and treat addictive disorders in their specialties.  \u003cp\u003eDrug and alcohol addictions occur commonly in medical populations; 25–50% of patients seen by primary care physicians have alcohol and drug disorders, with even higher prevalence in certain medical specialty populations. Drug use (including illicit drug use and actual or perceived misuse of prescribed medications), alcohol use, and what has been called unhealthy drinking are even more common in trauma centers and our society. Currently, there are no authoritative addiction texts that focus on the identification, intervention and management of either “addictive disorders in medical populations” or “medical complications in addiction populations”.\u003c\/p\u003e \u003cp\u003eNeurobiological progress in the field of addiction has been amazing and evidence-based treatments have developed at a phenomenal pace, with bench to office applications for tobacco, alcohol and drugs. Pharmacological and psychosocial treatments are described here in detail and in practical terms. The medical and mental complications of addiction are explained comprehensively throughout the text. Clinical considerations are the predominant theme, with the standards of clinical practice grounded in the most current research. The chapters include practical presentations of both clinical and research materials, with instruments for screening and assessment and treatment.\u003c\/p\u003e \u003cp\u003eIt will be useful for all those seeking information to help a patient or family with a tobacco, alcohol or drug problem. We hope this book can give answers and direction to the identification and management of addictions and their medical complications in patient populations.\u003c\/p\u003e \u003cp\u003eList of Contributors ix\u003c\/p\u003e \u003cp\u003ePreface xiii\u003c\/p\u003e \u003cp\u003eAcknowledgements xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart One Addictive Disorders and Medicine 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Addictive Disorders as an Integral Part of the Practice of Medicine 3\u003cbr\u003e\u003ci\u003eNorman S. Miller and Mark S. Gold\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Crime, Substance Use, and Mental Illness 15\u003cbr\u003e\u003ci\u003eJoel M. Silberberg, Milap A. Nowrangi, and Geetha Nampiaparampil\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Ethical Issues in Addiction Medicine 31\u003cbr\u003e\u003ci\u003eRoberta Springer Loewy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Natural History of Addictive Diseases 53\u003cbr\u003e\u003ci\u003eSteven A. Branstetter and Sabina Low\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Prevention Methods: School, Family, Community, Media and Public Policy Approaches 73\u003cbr\u003e\u003ci\u003eKarol L. Kumpfer and Paula Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Two Assessment and Diagnosis 97\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6 Screening and Diagnosis of Substance Use Disorders 99\u003cbr\u003e\u003ci\u003eNorman G. Hoffman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Clinical Pharmacology of Addicting Drugs 107\u003cbr\u003e\u003ci\u003eJiang Liu and Hartmut Derendorf\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Laboratory Diagnosis of Addicting Drugs 125\u003cbr\u003e\u003ci\u003eK.P. Gunaga and Satheesh Gunaga\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Cutaneous Manifestations of Drug Addiction 143\u003cbr\u003e\u003ci\u003eKendra Gail Bergstrom and Miguel R. Sanchez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Three Addictive Disorders and Clinical Diseases 155\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10 Addictive Disorders in Primary Care Medicine 157\u003cbr\u003e\u003ci\u003eRobert Mallin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Addictive Disorders in the Intensive Care Unit 167\u003cbr\u003e\u003ci\u003eTracy R. Luckhardt and Robert C. Hyzy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Addictive Disorders in Trauma Center Patients 181\u003cbr\u003e\u003ci\u003eMary C. McCarthy and Kathryn M. Tchorz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Addictive Disorders in Psychiatric Medicine 197\u003cbr\u003e\u003ci\u003eChristine Yuodelis-Flores, W. Murray Bennett, Charles Meredith, and Richard Ries\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Addiction and Short-Term Pain Management 219\u003cbr\u003e\u003ci\u003eSteven D. Passik, Lauren J. Rogak, Tatiana D. Starr, and Kenneth L. Kirsh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Prescription Opiate Medications: Clinical Assessment and Treatment of Tolerance and Dependence 227\u003cbr\u003e\u003ci\u003eNorman S. Miller, Lucy Chen, and Jianren Mao\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Substance Addiction and HIV Infection: Scope of the Problem and Management 239\u003cbr\u003e\u003ci\u003eGabriel Sarah, Clifford Martin, Myles Stone, Carol Schneiderman, and Stephen A. Klotz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Addictive Disorders in Cardiovascular Medicine 251\u003cbr\u003e\u003ci\u003eAlan H. Gradman and Nosheen Javed\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Alcohol Use and Diseases of the Eye 277\u003cbr\u003e\u003ci\u003eYoshimune Hiratsuka\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Addictive Disorders in Nutritional Diseases - From an Addictions Viewpoint 287\u003cbr\u003e\u003ci\u003eJames A. Cocores, Noni A. Graham, and Mark S. Gold\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Addictive Disorders in Nutritional Diseases - From a Nutritional Viewpoint 303\u003cbr\u003e\u003ci\u003eJennifer A. Nasser, Jessica B. Leitzsch, and Kiran Patel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Gastrointestinal Diseases Associated with Substance Addiction 313\u003cbr\u003e\u003ci\u003ePaul S. Haber and Abdullah Demirkol\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Addictive Disorders in Malignant Diseases 339\u003cbr\u003e\u003ci\u003eThomas J. Guzzo and Mark L. Gonzalgo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Substance Addiction and Gastrointestinal Malignancy 347\u003cbr\u003e\u003ci\u003eJason T. Hedrick and James R. Ouellette\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Renal Manifestations of Recreational Drug Use 361\u003cbr\u003e\u003ci\u003eGarland A. Campbell, W. Kline Bolton, and Mitchell H. Rosner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Addictive Disorder in Urological Diseases 377\u003cbr\u003e\u003ci\u003eHerman S. Bagga and Adam W. Levinson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Four Management of Addictive Disorders in Selected Populations 387\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e26 Management of Addictive Disorders in Medical Nursing Care Populations 389\u003cbr\u003e\u003ci\u003eKathleen L. Becker and Benita J. Walton-Moss\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Management of Addictive Disorders in Surgical Nursing Care Practice 411\u003cbr\u003e\u003ci\u003ePhyllis J. Mason\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Addictive Disorders in Psychology Practice 421\u003cbr\u003e\u003ci\u003eLisa J. Merlo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Addictive Disorders in Diseases of Women 439\u003cbr\u003e\u003ci\u003eDeborah V. Gross, C. Chapman Sledge, and Ellen A. Ovson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Children and Adolescents with ADHD: Risk and Protective Factors for Addictive Disorders 455\u003cbr\u003e\u003ci\u003eLarry Gray, Jennifer J. Park, and Michael E. Msall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 Addictive Disorders in the Elderly 467\u003cbr\u003e\u003ci\u003eAndrea Bial\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Five Treatment of Addictive Disorders 481\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e32 Pharmacological Therapeutics for Detoxification in Addictive Disorders 483\u003cbr\u003e\u003ci\u003eFiras H. Kobeissy, Carolina F. Braga, Noni A. Graham, and Mark S. Gold\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Pharmacological Therapeutics for Relapse Reduction in Addictive Disorders 503\u003cbr\u003e\u003ci\u003eLisa J. Merlo, Kimberly G. Blumenthal, Kendall Campbell, Morrow Omli, and Mark S. Gold\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Psychosocial Treatments for Addictive Disorders: Models, Settings, and Important Roles for Referring Physicians 525\u003cbr\u003e\u003ci\u003eJohn McKellar, John Finney, and Rudolf Moos\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Treatment Models for Comorbid Psychiatric and Addictive Disorders 541\u003cbr\u003e\u003ci\u003eJon D. Kassel, Adrienne J. Heinz, Daniel P. Evatt, and Ashley R. Braun\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Brief Interventions for Alcohol and Drug Problems 557\u003cbr\u003e\u003ci\u003eKristen L. Barry, Laurie Brockmann, and Frederic C. Blow\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Treatment Outcomes for Addictive Disorders 575\u003cbr\u003e\u003ci\u003eErin L. Winstanley, Shannon K. Bolon, and Marc Fishman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Biopsychosocial Recovery from Addictive Disorders 603\u003cbr\u003e\u003ci\u003eSara Jo Nixon and Robert A. Prather\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 619\u003c\/p\u003e  \"This book has a much wider focus than traditional books written about drug and alcohol addictions. This unique book is written by medical specialists who diagnose, treat and research addictive disorders in their specialties. Thus, it meets the needs of the typical medical practitioner who wants to learn about and treat patients with addictive disorders in their practices\". (HPC Market Watch, 14 December 2010)\u003cbr\u003e \u003cbr\u003e   \u003cp\u003e\"Specific topics include ethical issues in addictive medicine, the clinical pharmacology of addictive drugs, addiction and short-term pain management, alcohol use and diseases of the eye, renal manifestations of recreational drug use, addictive disorders in the elderly, and brief interventions for alcohol and drug problems.\" (\u003ci\u003eSciTech Book News\u003c\/i\u003e, December 2010)\u003c\/p\u003e  \u003cb\u003eDr. Miller\u003c\/b\u003e has spent 25 years in clinical practice and teaching and research at Cornell University Medical College, the University of Illinois at Chicago; he currently serves as a Clinical Professor at the College of Human Medicine at Michigan State University and works as a psychiatrist at Pine Rest Christian Mental Health Services in Grand Rapids.\u003cbr\u003e He has published 250 medical\/scientific articles, book chapters, and reviews, and 12 books on addiction medicine. He is a fellow in the American Psychopathological Association, and a member of the American Psychiatric Association, the American Society for Addiction Medicine, and the American National Professional Committees. He is a member of the Task Force on Treatment for the Office of National Drug Control Policy, Office of the President of the United States; a member of the Center for Substance Abuse Treatment on Screening, Assessment, and Treatment Planning for patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse; and co-chair of the Task Force for Undergraduate Medical Education, Association for Medical Education and Research ing Substance Abuse. For the American Society for Addiction Medicine, he is Regional Director of the Midwest Region and Editor of Principles of Addiction Medicine (First Edition), Program and Publication Committees. He has coordinated symposia, courses and workshops for the ASAM annual meeting.  \u003cp\u003e\u003cb\u003eMark S. Gold\u003c\/b\u003e, M.D. is an editor, author, teacher, pioneer, researcher and inventor, who has worked for nearly 40 years to create models for understanding the effects of tobacco, opiates and other drugs on the brain and behavior. He has developed models that have led to the discovery of new addiction treatments and has conceptualized novel hypotheses which yielded new approaches to the definition and treatment of addictions. Dr. Gold's pioneering work on the brain systems underlying the effects of opiate drugs led to a dramatic change in the way opiate action was understood and his seminal work on cocaine is considered classic translational science. Over the past decade, he has defined hedonic overeating as an addiction and developed animal and imaging models to develop new treatments for overeating and obesity. Most recently, he and his colleagues demonstrated that intravenously administered anesthetics and analgesics are exhaled in the air of operating rooms, present on surfaces, and available for second hand exposure. Dr. Gold and colleagues have explained the role of the workplace environment in physician drug abuse, addictions and relapse after successful treatment. Under his leadership, the Department of Psychiatry at the University of Florida has grown to 60 full-time clinical physicians and researchers with new projects and research groups in secondhand exposure models, functional brain imaging, self-administration, public health, impaired professionals, genomics, proteomics and nanotechnology. Dr. Gold has been awarded numerous national prizes and recognition for his work, leadership, and mentoring. Since beginning his career in research at the University of Florida in 1970, he has been the author of over 900 medical articles, chapters, and abstracts in journals for health professionals on a wide variety of psychiatric research subjects and has authored 12 professional books including practice guidelines, ASAM core competencies, and medical text books for primary care professionals. He is the author of 15 general audience books. According to a review in the Journal of the American Medical Association (JAMA 272:18, 1996), \"Mark S. Gold, M.D. the most prolific and brilliant of the addiction experts writing today... Dr. Gold has spent his career trying to bridge the gap in medical education and practice with the belief that addictions are diseases and that all physicians have a critical role in prevention and, if that fails, in early identification and prompt treatment.\"\u003c\/p\u003e  \u003cb\u003e\u003ci\u003eAddictive Disorders in Medical Populations\u003c\/i\u003e\u003c\/b\u003e has a much wider focus than traditional books written about drug and alcohol addictions.  This unique book is written by medical specialist who diagnose, treat and research addictive disorders in their specialities. Thus, it meets the needs of the typical medical practitioner who wants to learn about and treat patients with addictive disorders in their practices.  Because alcohol and drug problems are so prevalent and affect medical conditions profoundly, the medical specialist will improve their knowledge and skill to diagnose and treat addictive disorders in their specialties.  \u003cp\u003eDrug and alcohol addictions occur commonly in medical populations; 25-50% of patients seen by primary care physicians have alcohol and drug disorders, with even higher prevalence in certain medical specialty populations. Drug use (including illicit drug use and actual or perceived misuse of prescribed medications), alcohol use, and what has been called unhealthy drinking are even more common in trauma centers and our society. Currently, there are no authoritative addiction texts that focus on the identification, intervention and management of either \"addictive disorders in medical populations\" or \"medical complications in addiction populations\".\u003c\/p\u003e \u003cp\u003eAll physicians and health care professionals will encounter patients who suffer from addictive disorders as well as their primary reason for seeking treatment. This highly original book features chapters written by authors from many different specialties describing how they manage such patients, imparting an invaluable mix of clinical experience and scientific evidence. After consulting the book, a practitioner and researcher are bound to improve their clinical care and research on patients with addictive disorders.\u003c\/p\u003e \u003cp\u003eNeurobiological progress in the field of addiction has been amazing and evidence-based treatments have developed at a phenomenal pace, with bench to office applications for tobacco, alcohol and drugs. Pharmacological and psychosocial treatments are described here in detail and in practical terms. The medical and mental complications of addiction are explained comprehensively throughout the text. Clinical considerations are the predominant theme, with the standards of clinical practice grounded in the most current research. The chapters include practical presentations of both clinical and research materials, with instruments for screening and assessment and treatment.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eAddictive Disorders in Medical Populations\u003c\/i\u003e will be useful for all those seeking information to help a patient or family with a tobacco, alcohol or drug problem. We hope this book can give answers and direction to the identification and management of addictions and their medical complications in patient populations.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47988660601061,"sku":"NP9780470740330","price":321.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470740330.jpg?v=1761781159","url":"https:\/\/k12savings.com\/es\/products\/addictive-disorders-in-medical-populations-isbn-9780470740330","provider":"K12savings","version":"1.0","type":"link"}